Work

Combined concentrations and genetic variability of fibroblast growth factors predict cardiovascular risk in renal patients

Year: 2025

Type: article

Abstract: < 0.0001). These findings suggest that combining FGF biomarkers with genetic information may enhance CV risk stratification in CKD patients.

Source: iScience

DOI: 10.1016/j.isci.2025.114143

Authors: Laura González-Rodríguez, Manuel Martí-Antonio, Sonia Mota-Zamorano, Celia Chicharro, Bárbara Cancho, Álvaro Álvarez, Zoraida Verde, Ana Fernández-Araque, Fernando Bandrés, Nicolás Roberto Robles, Guillermo Gervasini

Institutions: Universidad de Extremadura, Instituto de Investigación Biomédica de Lleida, Universidad de Valladolid, Universidad Complutense de Madrid

Language: English

Topic: Fibroblast Growth Factor Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,240

Funders: European Commission, Junta de Extremadura, Instituto de Salud Carlos III, European Regional Development Fund

Awards: G1421577636, G1672546472, G2854544501, G310854839, ESTUDIO DEL SITEMA DE FACTORES DE CRECIMIENTO FIBROBLÁSTICO- KLOTHO COMO POTENCIAL BIOMARCADOR DE LA ENFERMEDAD RENAL CRÓNICA, G8138526645

OpenAlex ID: W4416426116

FWCI: 0.505

Cites: 46

Cited by: 2

Related to: